“Launch of strategic partner program.
Together with our members, Oslo Science City has launched a strategic partner program with eight leading global pharmaceutical companies: Novartis, GE HealthCare, GSK, Novo Nordisk, Thermo Fisher Scientific, AstraZeneca, Bayer and Roche.
“It is incredibly inspiring to see how the partner programme in Oslo Science City realises the purpose of facilitating active interaction between leading research environments, students, business actors and the public sector,” says Bente Mikkelsen, former director of the WHO and the South-Eastern Norway Regional Health Authority and special adviser for Oslo Science City.
Read article here.”
More posts featuring Oslo Science City.